Macquarie versus Goldman Sachs
Goldman may make muppets of its clients but remains the pre-eminent investment bank. Can Macquarie compete? Nathan Bell tills the ground for a future sell.
IAG CPS: Rotten tomatoes with Basel
More debt-like returns for equity-like financing. Gareth Brown explains how IAG’s ordinary shares offer higher potential returns for little additional risk.
Friday Fishing: A Navitas education
International students’ desire for a university degree has made for a very profitable business. But can it last?
Adios WAM Research
This listed investment company is a past mistake. After waiting 18 months to finesse an exit, the time has come to get out.
A clean sweep of LICs
The argument for investing in international LICs is much weaker now than it once was. Jason Prowd explains why they no longer make the cut.
ResMed v Cochlear a two horse race
James Greenhalgh puts both these medical device success stories through their paces to see which one wins out.
Friday Fishing: Adventures in tin
On this week’s fishing expedition, Gaurav Sodhi explains why one of two tin miners is worth baiting.
QBE share purchase plan arbitrage
Even if you don’t want to increase your investment in QBE shares, you should still consider participating in the share purchase plan.
Life's only certainty suits Invocare
Even the rich can’t avoid life’s only certainty. Gareth Brown explains why he loves this business but hopes to avoid becoming a customer for a while yet.
Incitec Pivot: A smelly business
There are only two reasons to buy this stock: Either it’s cheap or fertiliser prices are about to rise. Gaurav Sodhi examines the case for each.
Call 1300 880 160
Start a chat
Schedule a call
